Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases

Go back to Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases
(NASDAQ: RADX) Delayed: 0.95 -0.03 (3.06%)
Previous Close $0.98    52 Week High $ 
Open $0.95    52 Week Low $ 
Day High $0.99    P/E N/A 
Day Low $0.95    EPS $ 
Volume 5,301